Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Thoracic Outlet Syndrome Companies

ID: MRFR/MED/4100-HCR
85 Pages
Vikita Thakur
Last Updated: February 16, 2025
Thoracic Outlet Syndrome (TOS) is a condition characterized by compression of the nerves or blood vessels in the thoracic outlet, resulting in symptoms such as pain, numbness, and weakness in the upper extremities. Treatment for TOS may involve a combination of physical therapy, medications, and in some cases, surgical intervention. Companies associated with thoracic outlet syndrome treatment may develop and provide relevant medical devices, medications, or therapies.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Thoracic Outlet Syndrome Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)5.42%
2024 Market Size$ 0.8 Billion
2025 Market Size$ 0.84 Billion
2035 Market Size$ 1.43 Billion

Key Players

Medtronic
Stryker
Boston Scientific
Johnson & Johnson
Smith & Nephew
Zimmer Biomet
Opportunities
  • Rising Healthcare Expenditure
  • Advancements in Diagnostic Techniques
  • Growing Demand for Minimally Invasive Procedures

Top Industry Leaders in the Thoracic Outlet Syndrome Market

Thoracic Outlet Syndrome Market
ย 

Latestย Thoracic Outlet Syndromeย Companiesย Updates:

Medtronic receives FDA approval for its Intellisโ„ข neurostimulation system for treating chronic neuropathic pain associated with TOS, offering a non-surgical option for pain management.

Abbott announces positive early data from a Phase 2 clinical trial of its DRG stimulator for treating nerve compression in TOS, demonstrating potential for improved nerve function and pain relief.

Vertos Medical Group secures additional funding to expand its clinical trial of the VERTIGOโ„ข nerve decompression system for treating TOS, aiming to demonstrate its effectiveness in reducing symptoms and improving functional outcomes.

The Thoracic Outlet Syndrome Foundation (TOS Foundation) collaborates with medical institutions and researchers to advance TOS research and develop evidence-based treatment guidelines.

List ofย Thoracic Outlet Syndromeย Key companies in the market:

  • Piramal Critical Care
  • Pfizer Inc.
  • Validus Pharmaceuticals LLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi
  • Abbott
  • Bristol-Myers Squibb Company